ShareValue.ai

ShareValue scores for SLD.AU: Valuation 48, Quality 45, Growth 50, Health 53.

SLD.AU
ASX

Saluda Medical Inc

A$0.41(+2.50%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
48
Fair Value
Price vs Value
Quality
45
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
53
Moderate
Financial Stability
Momentum
15
Bearish
Price Trend

Company Details

About

Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesota.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026